Gotu kola (Centella asiatica), an herb used in Asian traditional medicine, has been studied for possible cognitive benefits, but current evidence does not show it prevents or reduces dementia risk in healthy people. Instead, rigorous research has focused on much narrower questions—whether it can help specific groups, such as stroke survivors with vascular brain damage, and whether it is safe to use at studied doses. The distinction matters: an association observed in lab studies or small trials is not the same as proof that the herb cuts dementia risk in the general population. What exists now is early clinical evidence in specific contexts and emerging safety data, not a demonstrated protective effect against dementia itself.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What Current Research Has Examined
- Association Versus Causation in Early Research
- Which Populations Have Been Studied and What Was Measured
- Known Side Effects and Safety Concerns
- Making a Practical Decision
- Where Research Is Heading
- Frequently Asked Questions
What Current Research Has Examined
Gotu kola has undergone rigorous scientific study at Oregon Health & Science University and other centers, shifting the herb from folklore to measurable clinical questions. The research has not centered on healthy aging or dementia prevention in the general public. Instead, studies have targeted people with existing cognitive impairment or brain injury—for example, stroke survivors with vascular cognitive problems.
One trial tested gotu kola extract at 750 mg and 1000 mg doses against folic acid in people recovering from stroke with cognitive decline, looking specifically at vascular cognitive impairment. A Phase 1 clinical trial measured how the herb's active compounds behave in the bodies of older adults with cognitive complaints, establishing safety and dose tolerability. These are narrow, targeted questions—not whether the herb prevents dementia in healthy people who take it as a supplement.
Association Versus Causation in Early Research
The gap between "we see an effect in a small trial" and "this prevents dementia" is enormous and often misunderstood. Early studies can suggest a herb affects memory or cognitive markers in lab settings or short-term human trials, but that is not the same as proof that it changes dementia risk over years or decades. The Alzheimer's Drug Discovery Foundation's Cognitive Vitality program rates Centella asiatica as having "insufficient evidence" for cognitive health in humans, meaning the available studies are too small, short, or limited in scope to draw firm conclusions.
A single positive result in stroke patients says nothing about whether the same dose helps someone without brain injury, or whether it works as a daily preventive over ten years. Causation requires evidence from large, long-term studies in the populations you care about. That evidence does not exist yet for gotu kola and dementia prevention.
Which Populations Have Been Studied and What Was Measured
Research has focused on people with established cognitive problems—stroke survivors and older adults with existing cognitive complaints—not people without disease. The measurements have included cognitive tests, brain imaging markers, and pharmacological safety (how the body processes the active compounds). Results in a stroke patient's recovery do not reliably predict effects in someone taking the herb to stay sharp in midlife.
Additionally, most studies have been small. A Phase 1 trial establishing safety in cognitively impaired older adults is a starting point for understanding tolerability, not proof of benefit. The lack of large, long-term studies in cognitively healthy people is the clearest sign that dementia prevention claims lack support.
Known Side Effects and Safety Concerns
Gotu kola can cause side effects including stomach upset, nausea, itching, and skin reactions. More rarely, it has been associated with liver inflammation.
Standardized extracts have been tested for safety in older adults, but long-term safety data in healthy people taking it preventively is limited. The herb can interact with medications and may increase the risk of bleeding or affect blood sugar control, making it unsuitable for people on certain prescriptions or with specific health conditions. Information on gotu kola safety, dosing, and drug interactions is available from medical references, and anyone considering it should review these warnings with a doctor—especially older adults, those on medications, or people with liver disease.
Making a Practical Decision
The practical takeaway is straightforward: gotu kola is not proven to prevent dementia or reduce dementia risk in healthy people. If you are interested in brain health, the evidence for other approaches—physical activity, cognitive engagement, sleep, social connection, and Mediterranean-pattern eating—is far stronger. If you have had a stroke or suffer from vascular cognitive impairment, a conversation with your neurologist about gotu kola might be warranted, since that is where limited evidence exists.
If you choose to use gotu kola as a supplement despite the lack of dementia-prevention proof, do so only under medical supervision. Report any side effects and ensure it does not interact with medications you take. Do not delay or replace evidence-based cognitive care with the hope that an unproven herb will protect your brain.
Where Research Is Heading
Ongoing work aims to clarify whether gotu kola's effects in stroke recovery might extend to other forms of cognitive decline. A Phase 1 trial assessed safety and target engagement of Centella asiatica in cognitive impairment, laying groundwork for larger studies.
If larger, longer trials in diverse populations show consistent benefit, the picture could change. For now, it has not, and consumers should base decisions on current evidence, not future possibility.
Frequently Asked Questions
Does gotu kola reduce my dementia risk?
No. Current evidence does not show that gotu kola prevents or reduces dementia risk in healthy people. Research has focused on stroke survivors and people with existing cognitive problems, not healthy aging.
Is gotu kola safe?
At studied doses, it appears tolerable for short-term use in older adults, but it can cause stomach upset, itching, skin reactions, and rarely liver inflammation. It may interact with medications and increase bleeding risk. Always discuss it with your doctor before use.
What actually does reduce dementia risk?
Physical activity, cognitive engagement, sleep, social connection, Mediterranean-pattern eating, blood pressure control, and managing diabetes and cholesterol have stronger evidence. Focus on those first.
